PMID: 9163608May 1, 1997Paper

Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies

British Journal of Haematology
D WangM J Robertson

Abstract

Ligation of CD40 inhibits apoptosis and stimulates proliferation of normal B cells, whereas ligation of CD95 (APO-1/Fas) induces apoptosis of activated lymphocytes. Aberrant signalling through the CD40 and CD95 antigens could thus participate in the pathogenesis of lymphoid malignancies. The expression and function of CD40 and CD95 on neoplastic B cells from patients with acute lymphoblastic leukaemia (ALL), chronic lymphocytic leukaemia (CLL) and non-Hodgkin's lymphoma (NHL) were examined. CD40 was expressed by all 30 B-cell tumours, whereas CD95 was detected on neoplastic B cells in only one of 10 cases of ALL, two of 10 cases of CLL, and three of 10 cases of NHL. Incubation with an agonistic CD95 monoclonal antibody (MoAb) did not augment apoptosis in any of the unstimulated B-cell neoplasms. CD40 triggering did not consistently inhibit spontaneous apoptosis, but ultimately stimulated the growth of neoplastic B cells in most cases. Furthermore, CD40 activation led to up-regulation of the CD95 antigen in all 30 B-cell neoplasms. Ligation of CD95 on CD40-activated tumour cells augmented apoptosis in five of 10 ALL, three of 10 CLL, and nine of 10 NHL cases. The degree of apoptosis induced by CD95 triggering was greater for NHL...Continue Reading

Citations

Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Nongnit Laytragoon-LewinHåkan Mellstedt
Feb 10, 1999·Medical Oncology·L M Osorio, M Aguilar-Santelises
Sep 4, 1999·Leukemia Research·J ChruścielZ M Kiliańska
Feb 13, 2001·Molecular Immunology·A B AlexandroffD D Taub
Oct 26, 1999·Immunology Today·R T CostelloD Olive
Sep 10, 2003·Experimental Hematology·Daphne Chapman-ShimshoniMichael Lishner
Jun 14, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hai LiVincent K Tsiagbe
Jul 26, 2002·British Journal of Haematology·Andrew P HaynesBrian J Thomson
Aug 9, 2001·Reviews in Clinical and Experimental Hematology·F Caligaris-Cappio
Aug 7, 2001·Reviews in Clinical and Experimental Hematology·E OrsiniR Foa
May 20, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·U BrassC Peschel
Mar 5, 2003·Annual Review of Immunology·Nicholas Chiorazzi, Manlio Ferrarini
Jul 20, 2007·Blood·Arnon P KaterThomas J Kipps
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter ChuThomas J Kipps
Jun 26, 2001·European Journal of Haematology·L M OsorioM Jondal
Apr 21, 2009·CNS Drugs·Gail S BellJosemir W Sander
Jun 18, 2009·Current Opinion in Neurology·Gail S Bell, Josemir W Sander
Aug 26, 1998·Leukemia & Lymphoma·L M OsorioM Aguilar-Santelises
Oct 24, 2000·Leukemia & Lymphoma·E J Schattner
Mar 1, 2006·Expert Opinion on Emerging Drugs·Karen W L Yee, Susan M O'Brien
Jan 5, 2001·Expert Opinion on Investigational Drugs·S M KornblauM Andreeff
Aug 29, 2002·Cancer Investigation·Elaine J Schattner
Jul 14, 2010·Best Practice & Research. Clinical Haematology·M T S BertilaccioF Caligaris-Cappio
Nov 26, 2003·Scandinavian Journal of Immunology·B VitaleB Jaksić
Mar 2, 2005·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Yair Herishanu, Aaron Polliack
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·M Carmen Hernandez, Susan J Knox
Sep 27, 2005·Leukemia Research·Peter GreaneyMichel A Duchosal

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.